Reuters logo
BRIEF-Pfizer Announces Updated Progression-Free Survival Results
December 6, 2017 / 12:43 PM / 12 days ago

BRIEF-Pfizer Announces Updated Progression-Free Survival Results

Dec 6 (Reuters) - Pfizer Inc:

* UPDATED DATA FROM PHASE 3 TRIAL OF IBRANCE® (PALBOCICLIB) PLUS LETROZOLE IN ER+, HER2- METASTATIC BREAST CANCER CONFIRM IMPROVEMENT IN PROGRESSION-FREE SURVIVAL

* - UPDATED DATA CONSISTENT WITH RESULTS FROM PRIMARY ANALYSIS FOR PALOMA-2

* SAYS ‍OVERALL SURVIVAL DATA WERE NOT YET MATURE AT TIME OF THIS UPDATED PFS ANALYSIS​

* - UPDATED DATA DEMONSTRATE THAT COMBINATION OF IBRANCE PLUS LETROZOLE REDUCED RISK OF DISEASE PROGRESSION BY 44 PERCENT Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below